Cargando…
Comprehensive characterization of central BCL-2 family members in aberrant eosinophils and their impact on therapeutic strategies
PURPOSE: Hypereosinophilia represents a heterogenous group of severe medical conditions characterized by elevated numbers of eosinophil granulocytes in peripheral blood, bone marrow or tissue. Treatment options for hypereosinophilia remain limited despite recent approaches including IL-5-targeted mo...
Autores principales: | Odinius, Timo O., Buschhorn, Lars, Wagner, Celina, Hauch, Richard T., Dill, Veronika, Dechant, Marta, Buck, Michele C., Shoumariyeh, Khalid, Moog, Philipp, Schwaab, Juliana, Reiter, Andreas, Brockow, Knut, Götze, Katharina, Bassermann, Florian, Höckendorf, Ulrike, Branca, Caterina, Jost, Philipp J., Jilg, Stefanie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8800915/ https://www.ncbi.nlm.nih.gov/pubmed/34654952 http://dx.doi.org/10.1007/s00432-021-03827-9 |
Ejemplares similares
-
Elevated RIPK3 correlates with disease burden in myelofibrosis
por: Dill, Veronika, et al.
Publicado: (2022) -
Venetoclax with azacitidine targets refractory MDS but spares healthy hematopoiesis at tailored dose
por: Jilg, Stefanie, et al.
Publicado: (2019) -
Transcriptomic profiling does not refine mastocytosis diagnosis
por: Buschhorn, Lars, et al.
Publicado: (2023) -
Selective inhibition of BCL-2 is a promising target in patients with high-risk myelodysplastic syndromes and adverse mutational profile
por: Reidel, Veronika, et al.
Publicado: (2018) -
The BCL-2 family member BOK promotes KRAS-driven lung cancer progression in a p53-dependent manner
por: Meinhardt, Anna-Lena, et al.
Publicado: (2022)